Docoh
Loading...

470 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
PRE 14A
VTGN VistaGen Therapeutics Inc
31 Dec 20
Preliminary proxy
5:21pm
8-K
VTGN VistaGen Therapeutics Inc
22 Dec 20
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
4:17pm
424B5
VTGN VistaGen Therapeutics Inc
20 Dec 20
Prospectus supplement for primary offering
7:00pm
FWP
VTGN VistaGen Therapeutics Inc
18 Dec 20
Free writing prospectus
6:38am
424B5
VTGN VistaGen Therapeutics Inc
17 Dec 20
Prospectus supplement for primary offering
5:13pm
8-K
VTGN VistaGen Therapeutics Inc
1 Dec 20
Other Events
4:24pm
8-K
VTGN VistaGen Therapeutics Inc
15 Nov 20
VistaGen Therapeutics Reports Fiscal 2021 Second Quarter Financial Results and Provides Highlights on its CNS Pipeline and Business Progress
7:00pm
10-Q
2021 Q2
VTGN VistaGen Therapeutics Inc
12 Nov 20
Quarterly report
4:36pm
8-K
VTGN VistaGen Therapeutics Inc
13 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:06pm
SC 13G
Rosalind Advisors, Inc.
18 Sep 20
VistaGen Therapeutics / Rosalind Advisors ownership change
4:56pm
8-K
VTGN VistaGen Therapeutics Inc
18 Sep 20
2020 Virtual Annual Meeting of Stockholders
9:14am
4
VTGN VistaGen Therapeutics Inc
24 Aug 20
VistaGen Therapeutics / JON S SAXE ownership change
4:31pm
8-K
VTGN VistaGen Therapeutics Inc
14 Aug 20
VistaGen Therapeutics Reports Fiscal 2021 First Quarter Financial Results and Highlights CNS Pipeline and Business Progress
5:24pm
10-Q
2021 Q1
VTGN VistaGen Therapeutics Inc
13 Aug 20
Quarterly report
4:26pm
8-K
VTGN VistaGen Therapeutics Inc
5 Aug 20
VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock
9:56pm
424B5
VTGN VistaGen Therapeutics Inc
3 Aug 20
Prospectus supplement for primary offering
8:45pm
424B5
VTGN VistaGen Therapeutics Inc
31 Jul 20
Prospectus supplement for primary offering
4:16pm
DEFA14A
VTGN VistaGen Therapeutics Inc
27 Jul 20
Additional proxy soliciting materials
4:52pm
DEF 14A
VTGN VistaGen Therapeutics Inc
27 Jul 20
Definitive proxy
4:51pm
8-K
VTGN VistaGen Therapeutics Inc
24 Jul 20
Regulation FD Disclosure
6:03am